C35H36F3N9O4 — CID 153306564
(1R,8E,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-N-[1-(2,2,2-trifluoroethyl)pyrazol-3-yl]-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide (PubChem CID 153306564) has the molecular formula C35H36F3N9O4 and a molecular weight of 703.73 g/mol. Its IUPAC name is (1R,8E,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-N-[1-(2,2,2-trifluoroethyl)pyrazol-3-yl]-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide.
| Compound Name | (1R,8E,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-N-[1-(2,2,2-trifluoroethyl)pyrazol-3-yl]-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide |
|---|---|
| PubChem CID | 153306564 |
| Molecular Formula | C35H36F3N9O4 |
| Molecular Weight | 703.73 g/mol |
| Exact Mass | 703.28 |
| IUPAC Name | (1R,8E,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-N-[1-(2,2,2-trifluoroethyl)pyrazol-3-yl]-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide |
| SMILES | CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)C/C=C/CCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4ccn(CC(F)(F)F)n4)N(C(=O)C2)[C@@H]1C3 |
| InChI | InChI=1S/C35H36F3N9O4/c1-20(48)31-25-12-23(24-15-39-21(2)40-16-24)11-22-7-5-3-4-6-8-29(49)41-18-34-13-26(33(51)42-28-9-10-45(43-28)19-35(36,37)38)47(27(34)14-34)30(50)17-46(44-31)32(22)25/h3,5,9-12,15-16,26-27H,4,6-8,13-14,17-19H2,1-2H3,(H,41,49)(H,42,43,51)/b5-3+/t26-,27+,34-/m0/s1 |
| InChIKey | ZVGHLIXSXOTVNW-JVBBNCDDSA-N |
| XLogP | 4.16 |
| TPSA | 157.00 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 51 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 703.73 |
| LogP ≤ 5 | 4.16 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|